Lara Diem - Concepedia

Author

Lara Diem

University Hospital of Bern ORCID

Also Known As

Diem, L. F., Diem, Lara, L Diem, L. Diem, Lara Diem, Lara F Diem

Publications

350

Citations

H-Index

Concepts

All Affiliations

University Hospital of Bern University of Bern Eginition Hospital National and Kapodistrian University of Athens

About

Lara Diem is an author at University Hospital of Bern specializing in autoimmune disease, neuroimmunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	26
2	Neurology	2	2	26
3	Public Health	1	1	13
4	Immunology	1	1	13
5	Neuroscience	1	1	13

Lara Diem

Publications

239

Citations

H-Index

Page 1

	Year	Citations
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course Greta Zoehner, Andrei Miclea, Anke Salmen, Therapeutic Advances in Neurological Disorders	2019	43
Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study Andrei Miclea, Anke Salmen, Greta Zoehner, CNS Neuroscience & Therapeutics	2018	32
Vaccine Hesitancy in Patients With Multiple Sclerosis Lara Diem, Christoph Friedli, Andrew Chan, Neurology Neuroimmunology & Neuroinflammation	2021	30
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19 Lara Diem, Livia Fregolente-Gomes, Jan D. Warncke, Journal of Central Nervous System Disease	2022	30
Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age Myriam Briner, Maud Bagnoud, Andrei Miclea, Therapeutic Advances in Neurological Disorders	2019	26
Multidimensional phenotyping of the <scp>post‐COVID</scp>‐19 syndrome: A Swiss survey study Lara Diem, Anina Schwarzwald, Christoph Friedli, CNS Neuroscience & Therapeutics	2022	24
Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod Lara Diem, Krassen Nedeltchev, Timo Kahles, Therapeutic Advances in Neurological Disorders	2018	14
Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis Mirjam Kolev, Stefan Diem, Lara Diem, Journal of Translational Autoimmunity	2022	14
Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD) Lara Diem, Helly Hammer, Robert Hoepner, International review of neurobiology Autoimmune DiseaseCns DisordersNeurological DisorderMedicineNeuroepidemiology	2022	13
Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients Christoph Friedli, Franca Wagner, Helly Hammer, Multiple Sclerosis Journal Neurological DisorderImmunodeficienciesImmunologyImmunotherapyInflammatory Arthritis	2022	13

Page 1